Anaphylaxis with depot medroxyprogesterone acetate (dmpa) in sri lanka: a casuality assessment

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: SENEVIRATNE, Manthi (Generl Sir John Kotelawala Defense University, Department of Pharmacy)
  • Co-author(s): Manthi Pabasari Seneviratne: Department of Pharmacy, Generl Sir John Kotelawala Defense University, Ratmalana, Sri Lanka
    S.S Shobia: Department of Pharmacy, Generl Sir John Kotelawala Defense University, Ratmalana, Sri Lanka
    Rohini Fernandopulle: Department of Pharmacology, Generl Sir John Kotelawala Defense University, Ratmalana, Sri Lanka
    Rajiva De Silva: Department of Immunology, Medical Research Institute, Colombo, Sri Lanka
  • Abstract:

    Background

    DMPA is a safe and effective method of contraception used by over 30 million women in over 90 countries. Between 2011 and 2013 an unusual cluster of anaphylactic reactions was reported to DMPA in Sri Lanka. No laboratory study has been done previously to determine if anaphylaxis is caused by the Active pharmaceutical ingredient(API) or

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login

FIP links